THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 99 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $433,821 | +250.4% | 41,915 | +267.3% | 0.00% | – |
| Q1 2023 | $123,820 | -27.4% | 11,412 | -24.9% | 0.00% | – |
| Q4 2022 | $170,544 | +48.3% | 15,200 | +33.7% | 0.00% | – |
| Q3 2022 | $115,000 | +12.7% | 11,368 | +1.1% | 0.00% | – |
| Q2 2022 | $102,000 | -34.2% | 11,249 | -30.8% | 0.00% | – |
| Q1 2022 | $155,000 | -98.7% | 16,260 | -95.7% | 0.00% | -100.0% |
| Q4 2016 | $12,095,000 | – | 379,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |